GSK & Wayne Gretzky, Along With His AI-Generated Younger Self, Join Forces For RSV Vaccine Campaign

In a ground-breaking move for the Canadian pharma industry, GSK, a leading biopharma company, is the first to dive into the world of artificial intelligence (AI) in their latest ad campaign.  

GSK is pioneering the integration of AI technology in pharma advertising with its Canadian Arexvy (RSV vaccine) ad campaign, featuring hockey legend Wayne Gretzky as he engages in a conversation with his AI-generated younger self. This innovative spot aims to dispel the common misconception that RSV only impacts young people, emphasizing the importance of RSV protection for older adults and challenging conventional wisdom. 

Respiratory Syncytial Virus (RSV) is a contagious seasonal illness that can affect all age groups, but for some can have serious consequences. For older adults and individuals with specific health conditions, RSV can lead to severe infections, pneumonia, hospitalization, and even death. 1,2 Arexvy is the first RSV vaccine for older adults to be approved in Canada and is currently available through pharmacies across the country. 

You can see the ad here.

Leave a Reply

%d bloggers like this: